The Mosaic Company (MOS)

Rating: SELL

SELL (5-tier) · income compounder · conviction: low

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).

Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = SELL because:

• Probability-weighted scenario value implies -13% vs spot
• Monte Carlo median implies -27% vs spot
• DCF fair value implies -65% vs spot
• Bear case (Structural — Nutrient Oversupply / Demand Reset) downside is -76% vs spot
• Net: reward/risk of 0.3× warrants a Sell.

Investment Thesis

At $21.19 the market pays roughly 0.6x EV/revenue and about 22x forward earnings, pricing Mosaic as a deep cyclical stuck near the low end of a nutrient cycle rather than a structurally impaired one. Our engine disagrees on where the cycle sits. The single Fertilizers segment carries a thin 3.1% trailing operating margin and a probability-weighted view that leans on the Structural and Downturn paths, which together hold 42% weight against a 32% Base. Recomputed scenario EPS spans $0.54 to $2.12, so most of the payoff distribution clusters below spot. The probability-weighted target of $17.64 sits 17% under the price, and the DCF anchor near $10 is lower still, penalising a capex glidepath rising to $1.50B while D&A of $1.05B lags and incremental ROIC reads under 1%. That combination drives the SELL. The most damaging risk is a genuine supply shock: constrained potash or phosphate output would lift realised prices and margin fast, and the thin-margin base means earnings are highly geared to any upside surprise in nutrient pricing.

The dashboard below is the whole argument on one page: spot ($21) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The bear leg the engine leans on is the Structural nutrient oversupply reset, and it is a real mechanism, not a hedge. New potash and phosphate capacity from lower-cost basins, weaker farmer affordability as grain prices ease, and a demand reset would push realised nutrient prices below cash-cost support for the marginal tonne. Mosaic's operating margin, already only 3.1%, would compress toward the 1.9% Structural path while the multiple de-rates to a trough level, collapsing EPS toward $0.54. With capex still climbing to $1.50B against $1.05B of depreciation, free cash flow thins precisely when it is most needed to defend the dividend, and net debt could breach 1.5x EBITDA. The result is a target below the 52-week low of $19.80.

Key Debate

Gross Margin explains 88% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.29 vs analyst floor +0.00 → delta +0.29 (n=22 mgmt / 10 Q&A; 30th pctile across the S&P book, z -0.6).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

News (last 365d, 1000 articles): avg ticker sentiment +0.06 (bullish 13% / bearish 11%)

Scenario Analysis

The tree runs from a structural 'Structural — Nutrient Oversupply / Demand Reset' downside ($5) to a 'Spike — Supply Shock (gas / geopolitics)' bull case ($41); the probability-weighted blend (PWEV $18) is -13% versus spot.

Scenario rationale — what each probability buys (the driver path behind every target):

• Structural — Nutrient Oversupply / Demand Reset (24%, $5). Structural impairment — nutrient glut / demand reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 4.63; probability: 0.24.
• Downturn — Price Trough (18%, $11). Cyclical downturn — nitrogen/potash/phosphate prices + natural-gas cost + crop demand weakens for 1–2 years before normalising. Drivers — implied_target: 10.0; probability: 0.18.
• Base — Mid-Cycle Nutrient Prices (32%, $19). Mid-cycle — normalised nitrogen/potash/phosphate prices + natural-gas cost + crop demand; disciplined capital allocation; steady returns. Drivers — implied_target: 18.33; probability: 0.32.
• Upcycle — Tight Nutrient Balance (18%, $32). Upside — supply shock / tight balance lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 31.26; probability: 0.18.
• Spike — Supply Shock (gas / geopolitics) (8%, $41). Upside tail — sustained tight conditions or a structural re-rate on supply shock / tight balance. Drivers — implied_target: 40.43; probability: 0.08.

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

DCF excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $15 and 41% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (88% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 9.5%, 15x terminal FCF multiple → $7. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 15.85x) implies $16. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Across all anchors the spread is 472% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Materials — Commodity

This name sits in the Materials — Commodity as a fertilizer. nitrogen/potash/phosphate prices + natural-gas cost + crop demand Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: DOW (commodity_chem) · LYB (commodity_chem) · ALB (lithium) · CF (fertilizer) · MOS (fertilizer)

Mapping note: name-level 'Structural — Nutrient Oversupply / Demand Reset' (24%) + 'Downturn — Price Trough' (18%) map to cluster Commodity Glut — Oversupply / Demand Reset (42%); name-level 'Upcycle — Tight Nutrient Balance' (18%) + 'Spike — Supply Shock (gas / geopolitics)' (8%) map to cluster Tight Market — Upcycle / Spike (26%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Commodity Glut — Oversupply / Demand Reset () — this name implies 42% vs the cluster house view of 42% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The commodity cycle is the shared macro driver. Driver — commodity-chemical / nutrient / lithium price cycle + feedstock costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 8% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 9.5% · Σ PV(FCF) $1B + PV(terminal) $2B = EV $3B; + net cash → equity $2B ÷ diluted shares 0.31B = $7/share (exit-multiple terminal).

• Gordon (perpetuity-growth) terminal at 2.5% → $7/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 0% vs WACC 10% → below WACC — the incremental build is value-dilutive.

Peer set

Peer-median fwd P/E → $16; EV/Rev → $81.

Weighted fair-value math

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Fertilizers (N / P / K) multiple (AI re-rating) (base 18x)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 0.2% of revenue; cash conversion (OCF/NI) 144% — cash-backed.

Catalyst Calendar

• 2026-08-04 (~27d) — Quarterly earnings — est. EPS $0.11 (AV EARNINGS_CALENDAR)
• 2026-09-30 (~84d) — Brazil (Mosaic Fertilizantes) volume/margin and grain-affordability update (authored)
• 2026-10-15 (~99d) — New global potash capacity ramp (BHP Jansen and others) milestone (authored)
• 2027-01-15 (~191d) — Potash / phosphate contract settlements (India, China, Brazil) (authored)

Forecast Track Record

• EPS surprise: beat 25.0% of the last 8 quarters; average surprise -26.0%.

Competitive Moat

Narrow moat. Mosaic's advantage is low-cost potash reserves (Saskatchewan) and phosphate integration plus scale, but it is a price-taker in a global nutrient commodity with no pricing control; the terminal multiple should stay cyclical-low (~8-10x mid-cycle EPS, ~0.6-0.8x EV/revenue), and only a durable tight-supply regime - not a spot spike - would justify anything higher.

Moat sources:

• Long-life low-cost potash reserves in Saskatchewan (favourable cost-curve position)
• Integrated phosphate mining and processing scale
• Logistics/distribution network in the Americas (Mosaic Fertilizantes in Brazil)
• NO pricing power - a price-taker in a globally traded nutrient commodity subject to oversupply

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

What the Market Is Pricing In

At the current price, the market pays 11.1× forward EPS, vs the house DCF terminal 15.0×, and a peer median 15.85×. The house DCF sits 65% below spot, so the market is pricing in more than the house case — roughly 3.6pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Peer Quality & Weighting

Quality-weighted forward P/E: 17.6× (simple median 15.85×). Direct peers count 100%, segment 50%, broad 25%.

Valuation-anchor screen: DCF (exit) (low-confidence cross-check (>50% below median)); DCF (Gordon) (low-confidence cross-check (>50% below median)). Anchor median 15.5. Extreme/excluded anchors carry no headline weight.

Historical-range cross-check: 52-week range $20–$37, centre $27 (+28% vs spot); spot sits at the 8th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Spike — Supply Shock (gas / geopolitics)): $41.

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (27.0); Capex intensity ±15% (19.0); Revenue CAGR ±3pp (4.0); Terminal × ±15% (2.0); WACC ±1pp (1.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Source Log

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 10%, terminal multiple 15×, FY+5 revenue $13B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Potash + phosphate realised selling price (segment MDA disclosure) below the level implied between the Base and Downturn paths (mid-single-digit annual price decline) (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). Realised nutrient prices are the primary earnings driver; a sustained decline below the mid-cycle band shifts weight from Base toward the Downturn and Structural paths.
• Consolidated adjusted operating margin below 3.1% (the midpoint between the Base 3.4% and Downturn 2.8% path op-margins) (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). Margin sitting under the Base/Downturn midpoint confirms cost pressure or price weakness is outrunning volume, validating the compressed-earnings leg of the bear scenarios.
• Annual capital expenditure above $1.50B (the top of the authored capex schedule) (2 consecutive prints → Mid-Cycle — Normalised Prices). Capex overrunning the sustaining glidepath while D&A of ~$1.05B lags erodes free cash flow and the ROIC on new spend, weakening the capital-return case in a soft price environment.
• Net-debt / trailing EBITDA above 1.5x (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). The balance sheet is near net-neutral (net debt $0.92B); leverage climbing through 1.5x in a price trough would constrain the dividend and buyback that underpin the mid-cycle valuation.
• Global grain stocks-to-use ratio (USDA WASDE) above the 5-year average by more than one full percentage point (2 consecutive prints → Commodity Glut — Oversupply / Demand Reset). Rising stocks-to-use signals slack crop demand and lower farmer affordability, the leading indicator for a nutrient demand reset that pushes realised prices toward the Structural path.

Fact / Inference / Speculation

• FACT: Spot $21; 52-week range $20–$37; engine rating SELL; base-case target $18 (-16%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
• INFERENCE: Triangulated FV $17 (-20% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: SELL

Defensive: rating SELL; triangulated fair value $13 (-39% vs spot) — the risk/reward is skewed to the downside on Gross Margin. The debate is Gross Margin — a fundamental call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

• No suitability assessment has been performed for any individual.
• Market data may be delayed or inaccurate; figures are as of the analysis date.
• Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
• Forecasts are uncertain; past performance is not indicative of future returns.
• The author or publisher may hold positions in securities mentioned.
• Users should verify information against primary sources (company filings) before acting.
• Investing involves risk of loss; there is no guarantee any target price is achieved.
• Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.